Key facts
| Price (PPV) | 107 MAD |
|---|---|
| Dispensing status | Schedule C — prescription only |
| Composition (DCI) | dexlanzoprazole |
| Class | Drugs for acid-related disorders |
| ATC code | A02BC06 |
| Manufacturer | PROMOPHARM (HIKMA) |
| Presentation | Boite de 14 |
| Hospital price | 66.90 MAD |
| Data collected on | 9/8/2026 |
Indications
Dexilant est indiqué chez les adultes et les adolescents à partir de 12 ans pour: la guérison de l'œsophagite érosive; le traitement d'entretien de l'œsophagite érosive guérie et le soulagement des brûlures d'estomac. le traitement de courte durée des brûlures d'estomac et des régurgitations acides associées au reflux gastro-œsophagien (RGO) symptomatique non érosif.
Find an open pharmacy
On-call pharmacies near you
Same-strength alternatives — cheapest first
Dexilant 30 mg (PROMOPHARM (HIKMA)) contains the same active substance as Dexilant 30 mg (Dexlanzoprazole) at the same strength, but in a different pack: Boite de 28 at 182.40 MAD, i.e. 6.51 MAD per unit against 7.64 MAD for Dexilant 30 mg. The public sale price is set by the Ministry of Health: it is identical in every pharmacy.
| Product | Manufacturer | Pack | PPV | Unit price |
|---|---|---|---|---|
| Dexilant 30 mg | PROMOPHARM (HIKMA) | Boite de 28 | 182.40 MAD | 6.51 / unit |
Substituting a generic is the pharmacist's decision; for medicines listed in schedules A, B and C it still requires a prescription. Public sale prices published by the Directorate of Medicines and Pharmacy, recorded on 9/8/2026.
About Dexilant 30 mg
Dexilant 30 mg belongs to the drugs for acid-related disorders therapeutic class. In Morocco, this drug is marketed by PROMOPHARM (HIKMA) and is among the pharmaceutical specialties referenced by the Ministry of Health.
For any question about the use, effects, or drug interactions of Dexilant 30 mg, consult your doctor or pharmacist. This information is provided for educational purposes and does not replace medical advice.
Frequently Asked Questions about Dexilant 30 mg
Answers to common questions from Moroccan patients about this drug.